Sir Jonathan Symonds CBENon-Executive Director
Sir Jonathan Symonds, CBE was appointed as Chairman to the GlaxoSmithKline plc Board on 1 September 2019. Jon has extensive international financial, life sciences and governance experience.
Jon served as an Independent Non-Executive Director of HSBC Holdings plc from April 2014, and as Deputy Group Chairman from August 2018, until his retirement from the Board in February 2020. He was previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner at KPMG. His governance experience includes roles as Non-Executive Director and Chair of the Audit Committees of Diageo plc, QinetiQ Group plc and Non-Executive Chair of Proteus Digital Health Inc.
Jon is currently a Non-Executive Director of Rubius Therapeutics, Inc and a Fellow of the Institute of Chartered Accountants in England and Wales.